Clinical trial
Efficacy and Safety of MitoQ in Improving Cancer Cachexia: A Clinical Study
NCT07836777 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xinxiang Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of MitoQ in Improving Cancer Cachexia: A Clinical Study
- Lead sponsor
- The First Affiliated Hospital of Xinxiang Medical College
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- October 10, 2026
- Completion date
- June 1, 2027
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cancer cachexia (cc), cancer patients with solid tumors